Please login to the form below

Article 50

This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.

‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

As mentioned above, draft Article 50 in particular confirms that all existing registered EU IPRs will be duplicated as comparable UK national rights at the end of the transition period. ... For example:. Geographical indications:Draft Article 50(2)

Latest news

UK pharma welcomes Brexit breakthrough

the Article 50 negotiations.
EU and UK pharma leaders appeal directly to Brexit negotiators

to collaborate with the EU" on the regulation of medicines after 30 March 2019 - the date when the UK officially leaves the EU under the two-year Article 50 process.
Boehringer Ingelheim calls for "strong and united" Europe

The UK's triggering of Article 50 is still dominating headlines and Boehringer's board member in charge of finance – Simone Menne – took pains to talk up the EU's achievements,
UK pharma strikes optimistic note as Brexit process begins

With Article 50 now triggered, the tough job of negotiating Brexit gets underway amid a clamour of requests and comments from private and public enterprises alike. ... The animal health sector also added its voice saying that the triggering of Article 50
Brexit begins as UK PM signs letter triggering Article 50

Brexit begins as UK PM signs letter triggering Article 50. Theresa May sets wheels in motion as Britain awaits EU response. ... UK Prime Minister Theresa May's letter triggering Article 50 is winging its way to European Council president Donald Tusk and

More from news
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest Intelligence

The Patient Safety Challenge

The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme
Macron, Merkel and May: implications of the 2017 elections for the life science industry

50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’transition period
Brexit: the facts (and the alternative facts)

The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.
Brexit: Implications for the pharma industry

Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Research Partnership has been ranked in the Pharma Times Pharma Fast 50. ... Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma
Brexit and Pharma: A match made in hell.

Countless other challenges remain, but we need to move forward, especially now that we have witnessed the triggering of article 50.
Random42 Named in Alantra’s Pharma Fast 50.

The annual ranking, which is presented by The PharmaTimes, was first published last year as the Catalyst Pharma Fast 50 and has since merged with Alantra, the global investment bank. ... For more on the Pharma Fast 50 read the full article: . For further

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Home based, Chief Medical Writer, Medical Communications: Excellent package

Business Unit Head, Medical Communications, London: Excellent package

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Senior Account Manager: Competitive salary commensurate with experience

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Editorial Director – Medical Education (MedComms): Neg

Home based, Principal Medical Writer, Medical Communications: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Client Services Director – Healthcare Advertising - London: Neg

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Account Manager: £40, 000 - £45, 000 benefits

Client Services Director - Med Comms: Great salary and bebefits

Home based, Editorial Team Leader, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Delivery Manager/ Head of Delivery – Executive Search: Neg

Subscribe to our email news alerts

PMHub

Add my company

Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....